Business
Currency:EUR
2024/FY
Stock NameRevenueRatio
BioPharma43.95B99.23%
Other339M0.77%
Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
United States19.99B45.13%
Other countries12.07B27.25%
Europe7.21B16.29%
Other revenues3.21B7.24%
France1.81B4.10%